These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7740453)

  • 41. Studies of the activation of factor VII bound to tissue factor.
    Rao LV; Williams T; Rapaport SI
    Blood; 1996 May; 87(9):3738-48. PubMed ID: 8611699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
    Hoffman M; Monroe DM; Roberts HR
    Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa.
    Rao LV; Rapaport SI; Hoang AD
    Blood; 1993 May; 81(10):2600-7. PubMed ID: 8490170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes.
    Contrino J; Hair GA; Schmeizl MA; Rickles FR; Kreutzer DL
    Am J Pathol; 1994 Dec; 145(6):1315-22. PubMed ID: 7992837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor.
    Andree HA; Contino PB; Repke D; Gentry R; Nemerson Y
    Biochemistry; 1994 Apr; 33(14):4368-74. PubMed ID: 8155655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the kinetics of factor X activation by tissue factor-factor VIIA.
    Nemerson Y
    Haemostasis; 1996 Oct; 26 Suppl 4():98-101. PubMed ID: 8979116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms.
    Wolberg AS; Monroe DM; Roberts HR; Hoffman MR
    Blood Coagul Fibrinolysis; 1999 Jun; 10(4):201-10. PubMed ID: 10390120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel immunoassay for the quantification of human tissue factor binding to activated factor VII.
    Weltermann A; Eichinger S; Kyrle PA
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):177-82. PubMed ID: 9622216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The local phospholipid environment modulates the activation of blood clotting.
    Shaw AW; Pureza VS; Sligar SG; Morrissey JH
    J Biol Chem; 2007 Mar; 282(9):6556-63. PubMed ID: 17200119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oyxsterols induce membrane procoagulant activity in monocytic THP-1 cells.
    Aupeix K; Toti F; Satta N; Bischoff P; Freyssinet JM
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):1027-33. PubMed ID: 8615754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A numerical analysis of factor X activation in the presence of tissue factor--factor VIIa complex in a flow reactor.
    Gir S; Slack SM; Turitto VT
    Ann Biomed Eng; 1996; 24(3):394-9. PubMed ID: 8734060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol.
    Mandal SK; Iakhiaev A; Pendurthi UR; Rao LV
    Blood; 2005 Jan; 105(1):153-60. PubMed ID: 15328160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of annexin V with phospholipid monolayers.
    Mukhopadhyay S; Cho W
    Biochim Biophys Acta; 1996 Feb; 1279(1):58-62. PubMed ID: 8624362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue factor activation: is disulfide bond switching a regulatory mechanism?
    Pendurthi UR; Ghosh S; Mandal SK; Rao LV
    Blood; 2007 Dec; 110(12):3900-8. PubMed ID: 17726162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity.
    Carson SD; Johnson DR
    Blood; 1990 Jul; 76(2):361-7. PubMed ID: 2369639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional and structural properties of urinary tissue factor.
    Lwaleed BA; Bass PS; Francis JL; Chisholm M
    Nephrol Dial Transplant; 1999 Mar; 14(3):588-96. PubMed ID: 10193804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: comment.
    Madsen JJ; Persson E; Olsen OH
    J Thromb Haemost; 2018 Jul; 16(7):1450-1454. PubMed ID: 29733494
    [No Abstract]   [Full Text] [Related]  

  • 58. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: reply.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Jul; 16(7):1454-1456. PubMed ID: 29734527
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of Cell Surface Lipids and Thiol-Disulphide Exchange Pathways in Regulating the Encryption and Decryption of Tissue Factor.
    Ansari SA; Pendurthi UR; Rao LVM
    Thromb Haemost; 2019 Jun; 119(6):860-870. PubMed ID: 30861549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system.
    Ansari SA; Pendurthi UR; Rao LVM
    Blood Adv; 2017 Nov; 1(25):2399-2413. PubMed ID: 29296890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.